Skip to main content
. 2008 Dec;2(4):865–874. doi: 10.2147/btt.s3355

Figure 3.

Figure 3

Flare-free survival of patients with juvenile idiopathic arthritis (JIA) treated with either abatacept or placebo. The graph demonstrates the proportion of patients without disease flare during the 6-month double-blind period. P value represents the comparison of the time to disease flare between the abatacept and placebo groups. Adapted from The Lancet, 372, Ruperto N, Lovell DJ, Quartier P, et al; Paediatric Rheumatology International Trials Organization; Pediatric Rheumatology Collaborative Study Group. 2008. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial, 383–91, Copyright © 2008 with permission from Elsevier.